EAS Publisher | The Hypereosinophilic Syndrome: About 2 Cases

The Hypereosinophilic Syndrome: About 2 Cases

DOI : https://doi.org/10.36349/easms.2025.v08i06.004

8 Downloads 10 Views

Hypereosinophilia syndrome is a group of rare diseases characterized by persistent blood eosinophilia (eosinophil count > 1.5 G/L for more than 6 months) associated with organ damage due to infiltration or degranulation of eosinophils. The diagnostic criteria include blood eosinophilia, involvement of multiple organs, and exclusion of other causes. There are three main subtypes: myeloproliferative, lymphocytic, and idiopathic. The first-line treatment is based on corticosteroids, and the prognosis of the disease is variable. Regular monitoring is essential. In this work, we report two distinct observations of HES.

TOP EDITORS

Dr. T. Selvankumar
Chief Editor
EAS Journal of Biotechnology and Genetics

Dr. James Kay, PhD
Chief Editor
EAS Journal of Psychology and Behavioural Sciences

Dr. Rejeesh Menon
Chief Editor
EAS Journal of Medicine and Surgery

Dr. S. Jayachandran
Chief Editor
EAS Journal of Dentistry and Oral Medicine

Dr. Md. Habibur Rahman
Chief Editor
EAS Journal of Pharmacy and Pharmacology

Dr. Benard Chemwei, PhD
Chief Editor
East African Scholars Multidisciplinary Bulletin

NFI Joseph Lon
Chief Editor
EAS Journal of Humanities and Cultural Studies

Prof. Dr. Nazir Ahmad Suhail
Chief Editor
East African Scholar Journal of Engineering and Computer Sciences

Dr. Hamid Osman Hamid
Chief Editor
EAS Journals of Radiology and Imaging Technology

Dr. BOUCENNA Mounir
Chief Editor
EAS Journal of Veterinary Medical Science

OPEN ACCESS JOURNALS

Dr. Afroza Begum

Lecturer, Dept. of Pharmacology and Therapeutics, Shaheed Monsur Ali Medical College & Hospital, Uttara, Dhaka-1230, Bangladesh

BEST AUTHOR

Of The Month

TRACK YOUR ARTICLE

Enter the Manuscript Reference Number (MRN)

Get Details